Ageitos JM, Sánchez-Pérez A, Calo-Mata P, Villa TG (2017) Antimicrobial peptides (AMPs): ancient compounds that represent novel weapons in the fight against bacteria. Biochem Pharmacol.
Albada B, Metzler-Nolte N (2017) Highly potent antibacterial organometallic peptide conjugates. Acc Chem Res 50(10):2510.
Allahou LW, Madani SY, Seifalian A (2021) Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer. Int J Biomater 2021:1–16.
Almaaytah A, Mohammed G, Abualhaijaa A, Al-Balas Q (2017) Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria. Drug Des Dev Ther 11:3159–3170.
Almaaytah A, Qaoud MT, Abualhaijaa A, Al-Balas Q, Alzoubi KH (2018) Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides. Infect Drug Resist.
Lewies A, Du Plessis LH, Wentzel JF (2019) Antimicrobial peptides: the Achilles’ heel of antibiotic resistance? Probiotics Antimicrob Proteins 11(2):370–381
Arias M, Piga K, Hyndman M, Vogel H (2018) Improving the activity of trp-rich antimicrobial peptides by Arg/Lys substitutions and changing the length of cationic residues. Biomolecules 8(2):19.
Assoni L, Milani B, Carvalho MR, Nepomuceno LN, Waz NT, Guerra MES, Converso TR, Darrieux M (2020) Resistance mechanisms to antimicrobial peptides in gram-positive bacteria. Front Microbiol.
Bahar A, Ren D (2013) Antimicrobial peptides. Pharmaceuticals 6(12):1543–1575.
Bahnsen JS, Franzyk H, Sayers EJ, Jones AT, Nielsen HM (2015) Cell-Penetrating antimicrobial peptides—prospectives for targeting intracellular infections. Pharm Res 32(5):1546–1556.
Baker JL, He X, Shi W (2019) Precision reengineering of the oral microbiome for caries management. Adv Dent Res.
Ballantine RD, McCallion CE, Nassour E, Tokajian S, Cochrane SA (2019) Tridecaptin-inspired antimicrobial peptides with activity against multidrug-resistant Gram-negative bacteria. MedChemComm 10(3):484–487.
Band V, Weiss D (2014) Mechanisms of antimicrobial peptide resistance in gram-negative bacteria. Antibiotics 4(1):18–41.
Bann SJ, Ballantine RD, Cochrane SA (2021) The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria. RSC Med Chem 12(4):538–551.
Bechinger B, Gorr SU (2017) Antimicrobial peptides: mechanisms of action and resistance. J Dent Res 96:254–260
Behrendt R, White P, Offer J (2016) Advances in Fmoc solid-phase peptide synthesis. J Peptide Sci.
Bellotti D, Remelli M (2022) Lights and shadows on the therapeutic use of antimicrobial peptides. Molecules 27(14):4584.
Bhattacharjee R, Nandi A, Sinha A, Kumar H, Mitra D, Mojumdar A, Patel P, Jha E, Mishra S, Rout PK, Panda PK, Suar M, Verma SK (2022) Phage-tail-like bacteriocins as a biomedical platform to counter anti-microbial resistant pathogens. Biomed Pharmacother.
Bin Hafeez A, Jiang X, Bergen PJ, Zhu Y (2021) Antimicrobial peptides: an update on classifications and databases. Int J Mol Sci 22(21):11691.
